Skip to main content
Erschienen in: Neurological Sciences 2/2012

01.04.2012 | Case Report

Cefixime-induced nonconvulsive status epilepticus

verfasst von: F. Anzellotti, L. Ricciardi, D. Monaco, F. Ciccocioppo, I. Borrelli, H. Zhuzhuni, M. Onofrj

Erschienen in: Neurological Sciences | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Nonconvulsive status epilepticus (NCSE) is an epileptic condition lasting >30 min, clinically manifested by an altered mental state and associated with continuous epileptiform activity on the electroencephalogram. NCSE is a common yet still under recognized condition and delay in diagnosis and treatment may be associated with increased mortality as well as cognitive/behavioral consequences. We described an epileptic female patient assuming carbamazepine (900 mg/day) and levetiracetam (3,000 mg/day), seizure free for more than 10 years, who developed NCSE during cefixime treatment, a third-generation cephalosporin compound that along with penicillins is classified within the b-lactam class of antibiotics. In our report we outline the importance and the difficulty to choose secure antibiotic treatment in epileptic patients, we discuss the possible mechanisms by which cephalosporins induce neurotoxicity and the need to stress family components questioning about new drugs assumed. Finally we highlight the value of the EEG recording to diagnose NCSE and treat it adequately and promptly.
Literatur
1.
Zurück zum Zitat Mutnick AH, Rhomberg PR, Sader HS, Jones RN (2004) Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999–2001). J Antimicrob Chemother 53:290–296PubMedCrossRef Mutnick AH, Rhomberg PR, Sader HS, Jones RN (2004) Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999–2001). J Antimicrob Chemother 53:290–296PubMedCrossRef
2.
Zurück zum Zitat Kolb R, Gogolak G, Huck S, Jascheck I, Stumpf C (1976) Neurotoxicity and CSF level of three penicillins. Arch Int Pharmacodyn Ther 222:149–156PubMed Kolb R, Gogolak G, Huck S, Jascheck I, Stumpf C (1976) Neurotoxicity and CSF level of three penicillins. Arch Int Pharmacodyn Ther 222:149–156PubMed
4.
Zurück zum Zitat Lin CS, Cheng CJ, Chou CH, Lin SH (2007) Piperacillin/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis. Am J Med Sci 333:181–184PubMedCrossRef Lin CS, Cheng CJ, Chou CH, Lin SH (2007) Piperacillin/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis. Am J Med Sci 333:181–184PubMedCrossRef
5.
6.
Zurück zum Zitat Hillsley RE, Massey EW (1991) Truncal asterixis associated with ceftazidime, a third-generation cephalosporin. Neurology 41(12):2008PubMed Hillsley RE, Massey EW (1991) Truncal asterixis associated with ceftazidime, a third-generation cephalosporin. Neurology 41(12):2008PubMed
7.
Zurück zum Zitat De Silva DA, Pan AB, Lim SH (2007) Cefepime-induced encephalopathy with triphasic waves in three Asian patients. Ann Acad Med Singap 36:450–451PubMed De Silva DA, Pan AB, Lim SH (2007) Cefepime-induced encephalopathy with triphasic waves in three Asian patients. Ann Acad Med Singap 36:450–451PubMed
8.
Zurück zum Zitat Capparelli FJ, Diaz MF, Hlavnika A, Wainsztein NA, Leiguarda R, Del Castillo ME (2005) Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function. Neurology 65:1840PubMedCrossRef Capparelli FJ, Diaz MF, Hlavnika A, Wainsztein NA, Leiguarda R, Del Castillo ME (2005) Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function. Neurology 65:1840PubMedCrossRef
9.
Zurück zum Zitat Bragatti JA, Rossato R, Ziomkowski S, Kliemann FA (2005) Cefepime-induced encephalopathy: clinical and electroencephalographic features in seven patients. Arq Neuropsiquiatr 63:87–92PubMedCrossRef Bragatti JA, Rossato R, Ziomkowski S, Kliemann FA (2005) Cefepime-induced encephalopathy: clinical and electroencephalographic features in seven patients. Arq Neuropsiquiatr 63:87–92PubMedCrossRef
10.
Zurück zum Zitat Thabet F, Al Maghrabi M, Al Barraq A, Tabarki B (2009) Cefepime-induced nonconvulsive status epilepticus: case report and review. Neurocrit Care 10(3):347–351PubMedCrossRef Thabet F, Al Maghrabi M, Al Barraq A, Tabarki B (2009) Cefepime-induced nonconvulsive status epilepticus: case report and review. Neurocrit Care 10(3):347–351PubMedCrossRef
11.
Zurück zum Zitat Lichaa H, Rachoin JS, Cerceo E, Rajput V, Surkis W (2010) Cefepime: an underrecognized cause of nonconvulsive status epilepticus. J Hosp Med 5(3):E18–E19PubMedCrossRef Lichaa H, Rachoin JS, Cerceo E, Rajput V, Surkis W (2010) Cefepime: an underrecognized cause of nonconvulsive status epilepticus. J Hosp Med 5(3):E18–E19PubMedCrossRef
12.
Zurück zum Zitat Martínez-Rodríguez JE, Barriga FJ, Santamaria J, Iranzo A, Pareja JA, Revilla M, dela Rosa CR (2001) Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med 111(2):115–119PubMedCrossRef Martínez-Rodríguez JE, Barriga FJ, Santamaria J, Iranzo A, Pareja JA, Revilla M, dela Rosa CR (2001) Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med 111(2):115–119PubMedCrossRef
13.
Zurück zum Zitat Maganti R, Jolin D, Rishi D, Biswas A (2006) Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function Epilepsy Behav 8(1):312–314 Maganti R, Jolin D, Rishi D, Biswas A (2006) Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function Epilepsy Behav 8(1):312–314
14.
Zurück zum Zitat Yost RL, Lee JD, O’Leary JP (1977) Convulsions associated with sodium cefazolin: a case report. Am Surg 43:417–420PubMed Yost RL, Lee JD, O’Leary JP (1977) Convulsions associated with sodium cefazolin: a case report. Am Surg 43:417–420PubMed
15.
Zurück zum Zitat Johnson H, Walter A (1945) Intraventricular penicillin: a note of warning. JAMA 127:217–219CrossRef Johnson H, Walter A (1945) Intraventricular penicillin: a note of warning. JAMA 127:217–219CrossRef
16.
Zurück zum Zitat Abanades S, Nolla J, Rodríguez-Campello A, Pedro C, Valls A, Farré M (2004) Reversible coma secondary to cefepime neurotoxicity. Ann Pharmacother 38(4):606–608PubMedCrossRef Abanades S, Nolla J, Rodríguez-Campello A, Pedro C, Valls A, Farré M (2004) Reversible coma secondary to cefepime neurotoxicity. Ann Pharmacother 38(4):606–608PubMedCrossRef
17.
Zurück zum Zitat Alpay H, Altun O, Biyikli NK (2004) Cefepime-induced non-convulsive status epilepticus in a peritoneal dialysis patient. Pediatr Nephrol 19(4):445–447PubMedCrossRef Alpay H, Altun O, Biyikli NK (2004) Cefepime-induced non-convulsive status epilepticus in a peritoneal dialysis patient. Pediatr Nephrol 19(4):445–447PubMedCrossRef
18.
Zurück zum Zitat Chedrawi AK, Gharaybeh SI, Al-Ghwery SA, Al-Mohaimeed SA, Alshahwan SA (2004) Cephalosporin-induced nonconvulsive status epilepticus in a uremic child. Pediatr Neurol 30(2):135–139PubMedCrossRef Chedrawi AK, Gharaybeh SI, Al-Ghwery SA, Al-Mohaimeed SA, Alshahwan SA (2004) Cephalosporin-induced nonconvulsive status epilepticus in a uremic child. Pediatr Neurol 30(2):135–139PubMedCrossRef
19.
Zurück zum Zitat Sugimoto M, Uchida I, Mashimo T, Yamazaki S, Hatano K, Ikeda F, Mochizuki Y, Terai T, Matsuoka N (2003) Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins. Neuropharmacology 45(3):304–314PubMedCrossRef Sugimoto M, Uchida I, Mashimo T, Yamazaki S, Hatano K, Ikeda F, Mochizuki Y, Terai T, Matsuoka N (2003) Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins. Neuropharmacology 45(3):304–314PubMedCrossRef
20.
Zurück zum Zitat Sugimoto M, Uchida I, Mashimo T, Yamazaki S, Hatano K, Ikeda F, Mochizuki Y, Terai T, Matsuoka N (2003) Evidence for the involvement of GABA(A) receptor blockage in convulsions induced by cephalosporins. Neuropharmacology 45:304–314PubMedCrossRef Sugimoto M, Uchida I, Mashimo T, Yamazaki S, Hatano K, Ikeda F, Mochizuki Y, Terai T, Matsuoka N (2003) Evidence for the involvement of GABA(A) receptor blockage in convulsions induced by cephalosporins. Neuropharmacology 45:304–314PubMedCrossRef
21.
Zurück zum Zitat Sugimoto M, Fukami S, Kayakiri H, Yamazaki S, Matsuoka N, Uchida I, Mashimo T (2002) The beta-lactam antibiotics, penicillin-G and cefoselis have different mechanisms and sites of action at GABA(A) receptors. Br J Pharmacol 135:427–432PubMedCrossRef Sugimoto M, Fukami S, Kayakiri H, Yamazaki S, Matsuoka N, Uchida I, Mashimo T (2002) The beta-lactam antibiotics, penicillin-G and cefoselis have different mechanisms and sites of action at GABA(A) receptors. Br J Pharmacol 135:427–432PubMedCrossRef
22.
Zurück zum Zitat Fujimoto M, Munakata M, Akaike N (1995) Dual mechanisms of GABA-A response inhibition by beta-lactam antibiotics in the pyramidal neurons of the rat cerebral cortex. Br J Pharmacol 116:3014–3020PubMed Fujimoto M, Munakata M, Akaike N (1995) Dual mechanisms of GABA-A response inhibition by beta-lactam antibiotics in the pyramidal neurons of the rat cerebral cortex. Br J Pharmacol 116:3014–3020PubMed
23.
Zurück zum Zitat Ohtaki K, Matsubara K, Fujimaru S, Shimizu K, Awaya T, Suno M, Chiba K, Hayase N, Shiono H (2004) Cefoselis, a beta-lactam antibiotic, easily penetrates the blood–brain barrier and causes seizure independently by glutamate release. J Neural Transm 111:1523–1535PubMedCrossRef Ohtaki K, Matsubara K, Fujimaru S, Shimizu K, Awaya T, Suno M, Chiba K, Hayase N, Shiono H (2004) Cefoselis, a beta-lactam antibiotic, easily penetrates the blood–brain barrier and causes seizure independently by glutamate release. J Neural Transm 111:1523–1535PubMedCrossRef
24.
Zurück zum Zitat Alkharfy KM, Kellum JA, Frye RF, Matzke JR (2000) Effect of ceftazidime on systemic cytokine concentrations in rats. Antimicrob Agents Chemother 44:3217–3219PubMedCrossRef Alkharfy KM, Kellum JA, Frye RF, Matzke JR (2000) Effect of ceftazidime on systemic cytokine concentrations in rats. Antimicrob Agents Chemother 44:3217–3219PubMedCrossRef
25.
Zurück zum Zitat Eggers V, Fugener K, Hein OV, Heyes Rommelspacher H, Kox WJ Spies CD MP (2004) Antibiotic-mediated release of tumour necrosis factor alpha and norharman in patients with hospital-acquired pneumonia and septic encephalopathy. Intensive Care Med 30:1544–1551PubMedCrossRef Eggers V, Fugener K, Hein OV, Heyes Rommelspacher H, Kox WJ Spies CD MP (2004) Antibiotic-mediated release of tumour necrosis factor alpha and norharman in patients with hospital-acquired pneumonia and septic encephalopathy. Intensive Care Med 30:1544–1551PubMedCrossRef
26.
Zurück zum Zitat Primavera A, Cocito L, Audenino D (2004) Nonconvulsive status epilepticus during cephalosporin therapy. Neuropsychobiology 49:218–222PubMedCrossRef Primavera A, Cocito L, Audenino D (2004) Nonconvulsive status epilepticus during cephalosporin therapy. Neuropsychobiology 49:218–222PubMedCrossRef
27.
Zurück zum Zitat Markham A, Brogden RN (1995) Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections. Drugs 49(6):1007–1022PubMedCrossRef Markham A, Brogden RN (1995) Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections. Drugs 49(6):1007–1022PubMedCrossRef
28.
Zurück zum Zitat Maganti R, Gerber P, Drees C, Chung S (2008) Nonconvulsive status epilepticus. Epilepsy Behav 12(4):572–586PubMedCrossRef Maganti R, Gerber P, Drees C, Chung S (2008) Nonconvulsive status epilepticus. Epilepsy Behav 12(4):572–586PubMedCrossRef
29.
Zurück zum Zitat Walker M, Cross H, Smith S, Young C, Aicardi J, Appleton R, Aylett S, Besag F, Cock H, DeLorenzo R, Drislane F, Duncan J, Ferrie C, Fujikawa D, Gray W, Kaplan P, Koutroumanidis M, O’Regan M, Plouin P, Sander J, Scott R, Shorvon S, Treiman D, Wasterlain C, Wieshmann U (2005) Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports. Epileptic Disord 7(3):253–296PubMed Walker M, Cross H, Smith S, Young C, Aicardi J, Appleton R, Aylett S, Besag F, Cock H, DeLorenzo R, Drislane F, Duncan J, Ferrie C, Fujikawa D, Gray W, Kaplan P, Koutroumanidis M, O’Regan M, Plouin P, Sander J, Scott R, Shorvon S, Treiman D, Wasterlain C, Wieshmann U (2005) Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports. Epileptic Disord 7(3):253–296PubMed
30.
Zurück zum Zitat Chatellier D, Jourdain M, Mangalaboyi J, Ader F, Chopin C, Derambure P, Fourrier F (2002) Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med 28:214–217PubMedCrossRef Chatellier D, Jourdain M, Mangalaboyi J, Ader F, Chopin C, Derambure P, Fourrier F (2002) Cefepime-induced neurotoxicity: an underestimated complication of antibiotherapy in patients with acute renal failure. Intensive Care Med 28:214–217PubMedCrossRef
31.
Zurück zum Zitat Jallon P, Fankhauser L, Du Pasquier R, Coeytaux A, Picard F, Hefft S, Assal F (2000) Severe but reversible encephalopathy associated with cefepime. Neurophysiol Clin 30:383–386PubMedCrossRef Jallon P, Fankhauser L, Du Pasquier R, Coeytaux A, Picard F, Hefft S, Assal F (2000) Severe but reversible encephalopathy associated with cefepime. Neurophysiol Clin 30:383–386PubMedCrossRef
32.
Zurück zum Zitat Kaplan PW (1999) Assessing the outcomes in patients with nonconvulsive status epilepticus: Nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol 16:341–352PubMedCrossRef Kaplan PW (1999) Assessing the outcomes in patients with nonconvulsive status epilepticus: Nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol 16:341–352PubMedCrossRef
33.
Zurück zum Zitat Niedermeyer E, Ribeiro M (2000) Considerations of nonconvulsive status epilepticus. Clin Electroencephalogr 31:192–195PubMed Niedermeyer E, Ribeiro M (2000) Considerations of nonconvulsive status epilepticus. Clin Electroencephalogr 31:192–195PubMed
34.
Zurück zum Zitat Sander JW, Perucca E (2003) Epilepsy and comorbidity: infections and antimicrobials usage in relation to epilepsy management. Acta Neurol Scand Suppl 180:16–22PubMedCrossRef Sander JW, Perucca E (2003) Epilepsy and comorbidity: infections and antimicrobials usage in relation to epilepsy management. Acta Neurol Scand Suppl 180:16–22PubMedCrossRef
Metadaten
Titel
Cefixime-induced nonconvulsive status epilepticus
verfasst von
F. Anzellotti
L. Ricciardi
D. Monaco
F. Ciccocioppo
I. Borrelli
H. Zhuzhuni
M. Onofrj
Publikationsdatum
01.04.2012
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 2/2012
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-011-0668-3

Weitere Artikel der Ausgabe 2/2012

Neurological Sciences 2/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.